Artivion (AORT) Income from Continuing Operations (2010 - 2026)
Artivion (AORT) reported Income from Continuing Operations of 1417000.0 for Q1 2026, up 380.59% on a YoY basis from 294843.43 in Q1 2025, and down 41.59% quarter-over-quarter from 2426000.0 in Q4 2025.
Artivion (AORT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Artivion has reported Income from Continuing Operations for 17 years, with the latest figure at 1417000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 380.59% year-over-year to 1417000.0; the trailing twelve-month figure through Mar 2026 stood at 11690000.0 (up 154.63% YoY), and the FY2025 full-year result was 9768000.0, up 173.12% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 1417000.0, down from 2426000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 7533000.0 in Q1 2024, with the low at 16483000.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 3062117.65 across 5 years, with a median of 2288000.0 in 2024.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations tumbled 314.67% — and 2025, when it soared 384.18%.
- Artivion's Income from Continuing Operations stood at 2169000.0 in 2022, then plunged by 283.26% to 3975000.0 in 2023, then plunged by 314.67% to 16483000.0 in 2024, then surged by 114.72% to 2426000.0 in 2025, then plunged by 41.59% to 1417000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 1417000.0 (Q1 2026), 2426000.0 (Q4 2025), and 6502000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Artivion | 1.02 Bn | 961.48 Mn | 75.45 Mn | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -505,000.00 |
| Dec 31, 2024 | -16.48 Mn |
| Sep 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Mar 31, 2023 | -13.53 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | -13.71 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -20.10 Mn |
| Sep 30, 2021 | 10.58 Mn |
| Jun 30, 2021 | -2.18 Mn |